Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts levodopa into dopamine. By blocking dopa decarboxylase, carbidopa increases the levels of levodopa that reach the brain, enhancing dopamine synthesis.

Another way drugs can impact neurotransmitter synthesis is by producing false transmitters. Methyldopa, for instance, is absorbed by adrenergic neurons and converted into α-methylnoradrenaline, a false transmitter. This compound displaces noradrenaline and alters receptor activation. It stimulates α1 adrenoceptors less effectively but activates presynaptic α2 receptors more efficiently, leading to an inhibitory feedback mechanism that reduces neurotransmitter production and release.

Certain neurotoxins, such as 6-hydroxydopamine and MPTP (1-methyl-4-phenyl-1,2,3,5-tetrahydropyridine), act as "Trojan horses" by being selectively taken up by neuronal junctions. Once inside, they transform reactive compounds that ultimately damage and destroy the nerve terminals—for example, 6-hydroxydopamine targets dopaminergic neurons, while MPTP affects dopaminergic and adrenergic neurons.

Additionally, a prodrug called droxidopa can cross the blood-brain barrier and is converted into noradrenaline by the enzyme dopa decarboxylase. This enhances sympathetic activity and can be used to treat conditions associated with low noradrenaline levels.

While drugs impacting neurotransmitter synthesis provide valuable insights into the modulation of adrenergic function, their clinical applications are often limited due to off-target effects and potential toxicity concerns.

Tags
Neurotransmitter SynthesisAdrenergic NeuronsCatecholamine SynthesisTyrosine HydroxylaseDopamine ProductionCarbidopaDopa DecarboxylaseFalse TransmittersMethyldopaNeurotoxins6 hydroxydopamineMPTPDroxidopaSympathetic ActivityClinical Applications

Du chapitre 6:

article

Now Playing

6.16 : Drugs Affecting Neurotransmitter Synthesis

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Vues

article

6.1 : Neurones adrénergiques : Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.9K Vues

article

6.2 : Récepteurs adrénergiques (récepteurs adrénergiques) : classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.8K Vues

article

6.3 : Récepteurs adrénergiques : ɑ Sous-type

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Vues

article

6.4 : Récepteurs adrénergiques : sous-type β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Vues

article

6.5 : Agonistes adrénergiques : agents à action directe

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.1K Vues

article

6.6 : Agonistes adrénergiques : agents à action indirecte

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Vues

article

6.7 : Agonistes adrénergiques : agents à action mixte

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

519 Vues

article

6.8 : Agonistes adrénergiques : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.2K Vues

article

6.9 : Agonistes adrénergiques : classification thérapeutique

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

499 Vues

article

6.10 : Agonistes adrénergiques : utilisations thérapeutiques

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

591 Vues

article

6.11 : Antagonistes adrénergiques : chimie et classification des inhibiteurs des récepteurs ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

650 Vues

article

6.12 : Antagonistes adrénergiques : actions pharmacologiques des inhibiteurs des récepteurs ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

407 Vues

article

6.13 : Antagonistes adrénergiques : chimie et classification des antagonistes des récepteurs β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

384 Vues

article

6.14 : Antagonistes adrénergiques : actions pharmacologiques des antagonistes des récepteurs β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

401 Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.